Synthesis, antimicrobial and antitubercular activities of some novel trihydroxy benzamido azetidin-2-one derivatives

Tropical Journal of Pharmaceutical Research

Volumn 10, Issue 2, 2011, Pages 219-229

  Ilango, K ^a   Arunkumar, S ^a  

^a SRM INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

Antimicrobial activity; Antitubercular activity; Azetidinone; Schiff bases; Synthesis

Indexed keywords

3 CHLORO 4 (2 CHLOROPHENYL) N (3,4,5 TRIHYDROXYBENZAMIDO) 2 AZETIDINONE; 3 CHLORO 4 (2 HYDROXY 3 METHOXYPHENYL) N (3,4,5 TRIHYDROXYBENZAMIDO) 2 AZETIDINONE; 3 CHLORO 4 (2 HYDROXYPHENYL) N (3,4,5 TRIHYDROXYBENZAMIDO) 2 AZETIDINONE; 3 CHLORO 4 (2 NITROPHENYL) N (3,4,5 TRIHYDROXYBENZAMIDO) 2 AZETIDINONE; 3 CHLORO 4 (3 HYDROXYPHENYL) N (3,4,5 TRIHYDROXYBENZAMIDO) 2 AZETIDINONE; 3 CHLORO 4 (3 NITROPHENYL) N (3,4,5 TRIHYDROXYBENZAMIDO) 2 AZETIDINONE; 3 CHLORO 4 (3,4 DIMETHOXYPHENYL) N (3,4,5 TRIHYDROXYBENZAMIDO) 2 AZETIDINONE; 3 CHLORO 4 (3,4,5 TRIMETHOXYPHENYL) N (3,4,5 TRIHYDROXYBENZAMIDO) 2 AZETIDINONE; 3 CHLORO 4 (4 CHLOROPHENYL) N (3,4,5 TRIHYDROXYBENZAMIDO) 2 AZETIDINONE; 3 CHLORO 4 (4 DIMETHYLAMINOPHENYL) N (3,4,5 TRIHYDROXYBENZAMIDO) 2 AZETIDINONE; 3 CHLORO 4 (4 HYDROXYPHENYL) N (3,4,5 TRIHYDROXYBENZAMIDO) 2 AZETIDINONE; 3 CHLORO 4 (4 METHOXYPHENYL) N (3,4,5 TRIHYDROXYBENZAMIDO) 2 AZETIDINONE; 3 CHLORO 4 (4 NITROPHENYL) N (3,4,5 TRIHYDROXYBENZAMIDO) 2 AZETIDINONE; 3 CHLORO 4 (PHENYL) N (3,4,5 TRIHYDROXYBENZAMIDO) 2 AZETIDINONE; ANTIINFECTIVE AGENT; CIPROFLOXACIN; ISONIAZID; KETOCONAZOLE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTITUBERCULAR ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYSICAL CHEMISTRY; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 79955941702     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: 10.4314/tjpr.v10i2.66567     Document Type: Article

References (23)

1. Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet 2003; 362: 887-899.
2. Angela GK. Research advances: Onions battle osteoporosis; New weapon in war on TB; smokers beware: Study shows increased cadmium levels in the brain may cause severe neurological disorders. J Chem Educ 2005; 82: 1114-1115
3. Alland D, Kalkut GE, Moss ARN. Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: Implications for rapid susceptibility testing. N Engl J Med 1994; 330: 1710-1715.
4. Davies PDO, Yew WW, Ganguly D, Smoking and tuberculosis: the epidemiological association and pathogenesis. Trans R Soc Trop Med Hyg 2006; 100: 291-298.
5. Whalen C, Horsburgh CR, Hom D. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995; 151: 129-135.
6. Sriram D, Yogeeswari P, Madhu K. Synthesis and in-vitro antimycobacterial activity of some isonicotinyl hydrazones. Bioorg Med Chem Lett 2005; 15: 4502-4505.
7. Gosling RD, Uiso LO, Sam NE, Bongard E, Kanduma EG, Nyindo M, Morris RW, Gillespie SH. Global Alliance for TB Drug Development: Scientific blueprint for tuberculosis drug development. Tuberculosis 2001; 81: 1-52.
8. Wong CS, Palmer GS, Cynamon MH. In-vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium kansasii to Amoxycillin and Ticarcillin in combination with Clavulanic acid. J Antimicrob Chemother 1988; 2: 863-866.
9. Sohi KK, Mittal N, Hundal MK, Khanduja KL. Gallic acid, an antioxidant exhibits antiapoptotic potential in normal human lymphocytes. J Nutr Sci Vitaminol 2003; 49: 221-227.
10. Krogh R, Yunes RA, Andricopulo AD. Structureactivity relationships for the analgesic activity of gallic acid derivatives. Farmaco 2000; 55: 730-735.
11. Anchana C, Aphiwat T, Jeremy D, Nuansri R. Antimicrobial gallic acid from Caesalpinia mimosoides. Food Chem 2007; 100: 1044-1048.
12. Sakaguchi N, Inoue M, Isuzugawa K, Ogihara Y, Hosaka K. Antiproliferative constituents in the plant seeds of Rhynchosia volubilis. Biol Pharm Bull 1999; 22: 471-475.
13. Nagendra PK, Yang B, Yang S, Yulong C, Ouming Z, Ashraf M, Jiang Y. Identification of phenolic compounds and appraisal of antioxidant and antityrosinase activities from litchi (Litchi sinensis Sonn.) seeds. Food Chem 2009; 116: 1-7.
14. Clader JW. Ezetimibe and other azetidinone cholesterol absorption inhibitors. Curr Top Med Chem 2005; 5: 243-256.
15. Gurupadayya BM, Gopal M, Padmashali B, Manohara YN. Synthesis and pharmacological evaluation of azetidin-2-ones and thiazolidin-4-ones encompassing benzothiazole. Indian J Pharm Sci 2008; 70: 572-577.
16. Andrew JW, Marvin JM. β-Lactams in synthesis: short synthesis of cobactin analogs Tetrahedron Lett 2007; 48: 5103-5105.
17. Vijaykumar MM, Nagaraja T, Shameer H, Jayachandran E, Sreenivasa G. Synthesis, characterization and antimicrobial activity of new N-substituted-3-chloro-2-azetidinones. Arch Pharm Sci Res 2009; 1: 31-39.
18. Patel HS, Patel VK. Synthesis of some new N-[4-N-(2,4-dichloro phenyl amino sulfonyl phenyl)-3-chloro-4-phenyl azetidin-2-ones]. Oriental J Chem 2002; 18: 513-516.
19. Okusa PN, Penge M, Devesschouwer M, Duez PJ. Direct and indirect antimicrobial effects and antioxidant activity of Cordia gilletii. J Ethnopharmacol 2007; 112: 476-483.
20. Burt SA, Reinders RD. Antibacterial activity of selected plant essential oils against Escherichia coli. Lett Appl Microbiol 2003; 36: 162-169.
21. Collins EA, Franzblow SG. Microplate alamar blue assay versus BACTEC 460 system for highthroughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother 1997; 41: 1004-1009.
22. Enayat IA, Ashraf HA. Synthesis and antitubercular activity of 6-chloro (unsubstituted)-2-methoxy-9-substituted acridine derivatives. Arch Pharm Res 2004; 27: 713-719.
23. Christopher MC, Richard BS. Monocyclic β-lactam antibiotics. Med Res Rev 1984; 4: 1-24.